Outset Medical receives Nasdaq delisting notice for bid price below $1.00 for 30 days

Outset Medical, Inc.

Notice dated Sept 23, 2024: closing bid price below $1.00 for 30 consecutive days violates Nasdaq Listing Rule 5450(a)(1).
Company has 180 calendar days, until March 24, 2025, to regain compliance by having $1.00+ closing bid price for 10 consecutive trading days.
If not compliant by deadline, may transfer to Nasdaq Capital Market and get additional 180-day period if eligible.
No immediate impact on listing; stock continues trading on Nasdaq Global Select Market during cure period.
Company states it will exercise diligent efforts but provides no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.